Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
- MACD is crossing MACD signal line at 0.1. MACD crossing signal line is bullish signal.
|Earning Growth (QoQ)|
|Revenue Growth (QoQ)|
|Held by Institutions %||76%|
|1 Day Vol Adjusted Return||0.1|
|1 Month Vol Adjusted Return||7.5|
|3 Month Vol Adjusted Return||9.3|
|6 Month Vol Adjusted Return||15.5|
|20 Days SMA Price ZScore||0.9|
|50 Days SMA Price ZScore||1.9|
|12 -26 Days PPO||14.6|
|1 Month Average Short Volume Ratio||36.1|
|1 Day Volume Change ZScore||-0.6|
|1 Month Daily Vol||9.5|
SANTA BARBARA, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the company will be participating in the upcoming SVB Leerink 10th Annual Global Healthcare Conference. Sientra’s management team is scheduled to present on Friday, February 26, 2021 at 3:40 p.m. ET. Event: SVB Leerink 10th Annual Global Healthcare ConferenceDate: Friday, February 26, 2021Time: 3:40 ...
The big shareholder groups in Sientra, Inc. ( NASDAQ:SIEN ) have power over the company. Large companies usually have...
Sientra Inc (NASDAQ: SIEN) prices its previously announced underwritten public offering of 5.4 million common shares at $6.75 per share, with gross proceeds of approximately $36.5 million. The offer price represents a discount of 16% from the last close of $7.99. The offering is expected to close by February 11, 2021. Underwriters have an option to purchase up to 811 thousand additional shares. Sientra intends to use the proceeds for general corporate purposes and acquire or invest in complement...
SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the pricing of its previously announced underwritten public offering. The Company will sell 5,410,628 shares of its common stock at a public offering price of $6.75 per share. The gross proceeds to Sientra, before deducting the underwriting discounts and commissions and estimated offering expenses, a...
SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that it has commenced an underwritten public follow-on offering of its common stock to be sold by the Company. In addition, the Company intends to grant the underwriters a 30-day option to purchase additional shares. The offering is subject to market conditions, and there can be no assurance as to wh...
On Thursday, medical aesthetic products manufacturer Sientra (NASDAQ: SIEN) reported preliminary results for its fourth quarter and full-year 2020. As of 1:08 p.m. EST, Sientra's shares are up by 16.1%, after jumping by as much as 31.7% earlier in the day. For its fourth quarter ending Dec. 31, 2020, Sientra expects to report net sales of $22.6 million.
Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outperformance in the core breast products segment SANTA BARBARA, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its preliminary unaudited financial results for the fourth quarter and full ...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 817 world-class investment firms that we track and now have access to the collective wisdom contained in […]